Introduction
The number of people living with human immunodeficient virus/acquired immune deficiency syndrome (HIV/AIDS) has steadily increased worldwide and reached 36.9 million in 2017 [
1]. In China, by the end of 2017, a cumulative total of 758,000 individuals were reported to be HIV infected, with more than 100,000 HIV-positive patients reported in the Guangxi Zhuang Autonomous Region [
2]. To effectively control the global HIV/AIDS epidemic, the Joint United Nations Programme on HIV/AIDS (UNAIDS) put forward a 90–90–90 target in 2013, aiming to 90% of people living with HIV aware about their status, treat 90% of these detected cases with antiretroviral therapy (ART), and achieve viral load suppression in 90% of those receiving treatment by 2020 [
3]. However, at present, only 60% of people with HIV infection are aware of their infectious status worldwide [
1], which, to a great degree, stands in the way of achieving the 90–90–90 target.
Timely initiation of ART has been considered as one of the most effective approaches to reduce the risk of HIV transmission. Early diagnosis of HIV is a crucial step to achieve the goal of early treatment [
4‐
6]. Nevertheless, almost half of HIV-positive patients are late diagnosed worldwide [
7]. In Europe, more than one-third of patients with HIV/AIDS are late diagnosis, resulting in delayed treatment [
8]. In China, a study conducted at the national level showed that 58.8% of patients with newly diagnosed HIV from 2006 to 2012 were late diagnosed [
9]. Another study indicated that the rate of advanced HIV disease in China ranged from 35.5% to 42.1% during 2010–2014 [
10]. Compared with those with early diagnosis, the patients with late diagnosis were worse in terms of immune system at diagnosis [
11,
12], and paid a higher cost for the therapy [
13]. Moreover, late diagnosed cases may cause inadvertent HIV transmission before they are aware of their HIV infection status [
14]. More importantly, late diagnosis is always associated with higher mortality and morbidity due to various opportunistic infections, especially tuberculosis, invasive bacterial, and fungal infections [
15]. A retrospective study revealed that among patients with advanced HIV disease, 57% had opportunistic infections and the majority of them were diagnosed when they developed AIDS-defined illness [
16].
The Guangxi Zhuang Autonomous Region, a province in western China, has the second highest HIV-infected reported cases in China, accounting for ~ 13% of total national HIV/AIDS cases. Even worse, the mortality among patients with HIV/AIDS in that region reached up to 34.9% by the end of 2017, which is far higher than the average of national level (24.0%). Late diagnosis is one of the important predictors of HIV/AIDS-related mortality [
17]. However, information about HIV late diagnosis in Guangxi, in addition to the influencing factors, should be further explored. To date, only a few studies reported the situation in a county or a city in Guangxi [
18]. In addition, even in other cities of mainland China, only a small number of studies have identified the factors associated with late HIV diagnosis in several cities [
19‐
22]. Reducing HIV/AIDS epidemic is extremely urgent for Guangxi through some effective targeted prevention strategies. Therefore, the present study investigated the situation of late presentation (CD4 < 350/mm
3, or AIDS-defining event regardless of CD4 count) and advanced HIV disease (CD4 < 200/mm
3, or AIDS-defining event regardless of CD4 count) among patients with newly diagnosed HIV/AIDS. Also, the influencing factors, including demographic or socioeconomic variables associated with late presentation and advanced HIV disease, were analyzed.
Methods
Study population
All patients with newly diagnosed HIV/AIDS who registered in the HIV surveillance system of Guangxi Centers for Disease Control (CDC) between January 2012 and December 2016 were included in this study. The inclusion criteria were as follow: (1) HIV positive, (2) aged at least 15 years, (3) had a CD4+ T-cell count during diagnosis (it was defined as the first CD4+ T-cell count detection within 3 months after diagnosis), (4) were ART-naïve when the first CD4+ T-cell count was detected. This study excluded HIV-1 infected patients who had no record of CD4+ T-cell count, had the first CD4+ T-cell count detection longer than 3 months after diagnosis, and were on ART before the CD4+ T-cell count was detected.
Study design
A cross-sectional study was conducted to investigate the prevalence of late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS and the influencing factors associated with late presentation and advanced HIV disease. Demographic or socioeconomic data, including gender, age, region, marital status, occupation, ethnic, educational attainment, and HIV transmission route, as well as clinical data, such as CD4+ T-cell count at diagnosis, year of HIV diagnosis, and reason for HIV testing, were collected from the records of HIV surveillance system and used for subsequent analyses.
Definitions
CD4
+ T-cell counts were determined by flow cytometry. According to a consensus definition as presented by the European Late Presenter Consensus working group [
23], late presentation was defined as, a patient diagnosed with the first CD4
+ T-cell count < 350/mm
3, or a patient with a AIDS-defining illness regardless of CD4
+ T-cell count during diagnosis. Besides, advanced HIV disease was defined as a patient with a CD4
+ T-cell count < 200/mm
3, or a patient with an AIDS-defining illness regardless of CD4
+ T-cell count during diagnosis.
Statistical analysis
The trends of late presentation and advanced HIV disease were analyzed using the Chi square test. The risk factors associated with late presentation and advanced HIV disease were analyzed by univariate and multivariate logistic regression analyses. The univariate analysis explored variables (attributes) one by one. Variables could be either categorical or numerical. The multivariate analysis was based on the statistical principle of multivariate statistics, which involved observation and analysis of more than one statistical outcome variable at a time. A P-value less than 0.05 was considered statistically significant. Statistical analyses were performed using the SPSS16.0 software (IBM, NY, USA).
Discussion
This novel study investigated the prevalence of late presentation and advanced HIV disease in Southwestern China. One strength of this study was its large sample size. Further, the completeness of the data was high, because more than 94% of the newly diagnosed patients were included in this study, and also the important information, including CD4 T-cell counts during diagnosis or the first entry into care and AIDS-defining illnesses, was available.
The study showed that the local prevalence of late presentation reached up to ~ 70% in recent years, indicating that late diagnosis is a serious problem in Guangxi, China The prevalence of late presentation in Guangxi not only is higher than those in other countries [
24,
25], but also higher than those in other regions in China, including Zhejiang province [
26] and Guangzhou City [
27]. Besides, the prevalence of advanced HIV disease in Guangxi is higher compared with national level in China (42.1% vs. 35.5%) [
10]. Late presentation is associated with an increased rate of AIDS/deaths, particularly in the first year after HIV diagnosis [
23]. Therefore, a high prevalence of late presentation and advanced HIV disease may be an important factor for the high mortality among patients with HIV/AIDS in Guangxi. Reducing late HIV diagnosis and advanced HIV disease is considered a public health priority and continues to be a great challenge in most countries [
28,
29]. To achieve this goal, the US CDC and the US Preventive Services Task Force newly recommended one-time HIV testing for persons aged 15–65 years as part of routine health care [
30,
31].
This study revealed that men were associated with late presentation, which was consistent with the results of previous studies. A meta-analysis which including 32 studies, revealed that the pooled aOR of men with advanced HIV disease and late presentation compared with women was 1.73 and 1.38, respectively [
32]. One possible reason was that HIV-infected women generally experienced a slower disease development compared with men, which was corroborated by the fact that women tended to have higher CD4
+ lymphocyte counts compare with men with similar infection time [
33]. Nevertheless, two other studies from Belgium and North-East Scotland [
34,
35] suggested that women were more likely diagnosed late. This discrepancy might be contributed to the fear of stigma and discrimination, being a significant issue particularly among women in certain areas in the world.
Older age was also found to be a factor associated with late presentation in this study, which was similar to the results of other previous studies [
36,
37]. This might be due to several reasons. The HIV symptoms in older people were misjudged as other illnesses for being older [
38,
39], or the elderly were hard to be a target of HIV prevention efforts [
40]. Psychological factors, such as depression, associated with delayed diagnosis and late testing [
41], are more common in older adults, which may also hinder access to health care [
42]. The study indicated that older age was also associated with advanced HIV disease, which was different from the findings of some similar studies [
43‐
45].
In this study, PWID and heterosexuals were more likely to be associated with late presentation and advanced HIV disease compared with MSM. The reason, possibly, was that the access or barriers of HIV testing for different risk populations might be different. Most of PWID were reluctance to access the health care system, while they were asymptomatic [
46,
47]. However, MSMs were more likely to have an HIV testing due to various encouragement strategies, such as opt-out HIV testing (tests are routinely offered to all patients) at STI clinics and the encouragement of high-risk MSMs for HIV testing every 6 months [
48]. For heterosexuals, effective HIV testing strategies are lacking. Hence, a more forward-looking proposal of HIV testing in different health care settings is urgently needed to reduce the high rates of late diagnosis.
Diagnosed HIV in hospital and those that had HIV testing before accepting blood transfusion were two relatively strong factors associated with late presentation and advanced HIV disease, suggesting that patients didn’t visit a doctor until the clinical symptoms appeared and treatment was initiated at a later disease stage. The other possible explanations could be that the clinical manifestations lack specificity, contributing to the missed diagnosis of HIV infection by health care professionals. Health care professionals should play an important role in recommending HIV testing in the presence of AIDS defining diseases as well as for the specific HIV indicator conditions [
49]. On the contrary, the higher CD4 lymphocyte count at presentation was found among patients with an HIV-positive partner or those who were diagnosed by premarital/pregnancy screening, medical examination, penitentiary, pre-surgery and VCT, indicating that routine HIV testing is an effective measure to reduce late diagnosis. A recent report has shown that the lack of routine HIV testing is a general health challenge, associated with a poor medical level in rural areas [
50]. Hence, efforts should be made to detect patients with HIV/AIDS promptly.
This study had several limitations. First, participants of this study were from one province of China, thus leading to a selection bias. Nevertheless, the large sample size and multicenter study in essence (the subjects came from all counties and cities across Guangxi province) could partially reduce the bias. Second, the details of the category of AIDS defining illness were unavailable. Third, variables used in this study were somewhat limited because this study was actually a retrospective cross-sectional investigation, and some influencing factors might have been missed. Further study focusing on the association of knowledge, attitude, and practice of patients toward HIV/AIDS and the clinical symptoms of patients with late diagnosis, should be conducted to better identify the influencing factors and control late diagnosis.
Authors’ contributions
LY, HL, ZYS, BYL, JJJ, JGH designed the study and provided the correlative knowledge. CXZ, BZ, JL, JZL, RFC, XWP collected and provided the data, including data extraction and data cleaning. XH, CYN, NZ, YYL, PJP, XL, GHL analyzed the data. XH, BYL, CXZ drafted of the manuscript. All authors read and approved the final manuscript.